Simulations Plus (NASDAQ:SLP – Get Free Report) had its price objective increased by stock analysts at TD Cowen from $16.00 to $19.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the technology company’s stock. TD Cowen’s target price would indicate a potential downside of 3.06% from the stock’s current price.
A number of other equities research analysts have also weighed in on the stock. BTIG Research cut shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. KeyCorp restated a “sector weight” rating on shares of Simulations Plus in a research report on Wednesday, October 29th. Citigroup reaffirmed a “market perform” rating on shares of Simulations Plus in a research note on Tuesday. Cowen reissued a “hold” rating on shares of Simulations Plus in a research note on Thursday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $25.00.
View Our Latest Report on Simulations Plus
Simulations Plus Trading Up 8.6%
Simulations Plus (NASDAQ:SLP – Get Free Report) last announced its quarterly earnings data on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 13.56%. The firm had revenue of $18.42 million for the quarter, compared to analysts’ expectations of $18.05 million. During the same period in the prior year, the business posted $0.17 earnings per share. On average, equities research analysts predict that Simulations Plus will post 1.09 EPS for the current year.
Institutional Trading of Simulations Plus
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new stake in Simulations Plus in the fourth quarter valued at $170,000. Green Alpha Advisors LLC bought a new stake in shares of Simulations Plus during the 4th quarter valued at about $257,000. JPMorgan Chase & Co. increased its position in shares of Simulations Plus by 154.7% during the third quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock valued at $2,526,000 after buying an additional 101,822 shares during the period. Tudor Investment Corp ET AL purchased a new position in shares of Simulations Plus during the third quarter valued at about $1,810,000. Finally, Connors Investor Services Inc. raised its stake in Simulations Plus by 59.8% in the third quarter. Connors Investor Services Inc. now owns 21,570 shares of the technology company’s stock worth $325,000 after buying an additional 8,070 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.
More Simulations Plus News
Here are the key news stories impacting Simulations Plus this week:
- Positive Sentiment: Revenue slightly beat Street expectations and management pointed to strong bookings and services momentum, which supports near‑term revenue visibility and the company’s longer‑term recovery narrative. Business Wire Release
- Positive Sentiment: An analyst at TD Cowen raised the price target (to $19) and maintained a “hold,” a signal that some sell‑side views are stabilizing and may provide support to the stock. Benzinga Note
- Neutral Sentiment: Full earnings call transcripts and slide materials are available for investors who want details on product trends, backlog and guidance assumptions; these give transparency but contain mixed signals. Earnings Call Transcript (Seeking Alpha)
- Neutral Sentiment: Trading volume is elevated versus its average, indicating strong investor interest and greater price sensitivity to news flow. MarketBeat Quote
- Negative Sentiment: The quarter missed consensus EPS ($0.13 vs. $0.18 expected), and software revenue declined ~17% year‑over‑year — the software slowdown is the main headwind to near‑term margins and growth expectations. Investing.com Coverage
- Negative Sentiment: Profitability metrics remain under pressure (reported negative net margin and a weaker EPS vs. prior year), which could limit upside until software trends stabilize or services/AI initiatives convert to consistent earnings growth. Zacks Analysis
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Stories
- Five stocks we like better than Simulations Plus
- Why Trump and Musk suddenly care about Fort Knox
- Best $19 you’ll spend this year.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
